{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:54:34Z","timestamp":1762458874304,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.canrad.2010.11.012","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T04:11:43Z","timestamp":1295151103000},"page":"77-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Soraf\u00e9nib et radioth\u00e9rapie dans le carcinome h\u00e9patocellulaire"],"prefix":"10.1016","volume":"15","author":[{"given":"N.","family":"Girard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mornex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2010.11.012_bib0005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0010","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2010.11.012_bib0015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies\u00a0\u2013\u00a0mature results of the French Phase II RTF-1\u00a0trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.11.012_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canrad.2010.11.011","article-title":"Radioth\u00e9rapie externe des carcinomes h\u00e9pato-cellulaires","volume":"15","author":"Girard","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2010.11.012_bib0025","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21012","article-title":"Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"103","author":"Liang","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2010.11.012_bib0030","doi-asserted-by":"crossref","unstructured":"Pao W, Girard N. New driver mutations in non-small-cell lung cancer. doi:10.1016\/S1470-2045(10)70087-5.","DOI":"10.1016\/S1470-2045(10)70087-5"},{"key":"10.1016\/j.canrad.2010.11.012_bib0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2010.11.012_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0045","first-page":"4278","article-title":"The Ras radiation resistance pathway","volume":"61","author":"Gupta","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2010.11.012_bib0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1158\/0008-5472.579.65.2","article-title":"Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3\u00a0signals in TK6\u00a0human lymphoblastoid cells","volume":"65","author":"Samuni","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2010.11.012_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1269\/jrr.45.557","article-title":"Activation of c-kit by stem cell factor induces radioresistance to apoptosis through ERK-dependent expression of survivin in HL60\u00a0cells","volume":"45","author":"Jalal Hosseinimehr","year":"2004","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2010.11.012_bib0060","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/sj.onc.1209706","article-title":"Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9\u00a0expression through PI3K\/Akt\/NF-kappaB signal transduction pathway","volume":"25","author":"Cheng","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canrad.2010.11.012_bib0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.MP.0000071841.17900.69","article-title":"Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?","volume":"16","author":"Moon","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0070","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.510280607","article-title":"Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells","volume":"28","author":"Yoshiji","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.canrad.2010.11.012_bib0075","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1158\/1078-0432.CCR-05-2721","article-title":"Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma","volume":"12","author":"Chung","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2010.11.012_bib0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2005.01.009","article-title":"Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1","volume":"75","author":"Williams","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","article-title":"Tumor microenvironmental physiology and its implications for radiation oncology","volume":"14","author":"Vaupel","year":"2004","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.canrad.2010.11.012_bib0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.canrad.2010.11.012_bib0100","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1158\/0008-5472.CAN-07-1473","article-title":"Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation","volume":"67","author":"Plastaras","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2010.11.012_bib0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2009.07.1725","article-title":"Angiogenic blockade and radiotherapy in hepatocellular carcinoma","volume":"78","author":"Chi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.11.012_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/0044011-200929010-00007","article-title":"Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma","volume":"29","author":"Hsieh","year":"2009","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.canrad.2010.11.012_bib0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1748-717X-5-12","volume":"5","author":"Zhao","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0120","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1200\/JCO.2007.15.8451","article-title":"Bowel perforation after radiotherapy in a patient receiving sorafenib","volume":"26","author":"Peters","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2010.11.012_bib0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canrad.2009.01.002","article-title":"Toxicit\u00e9 de l\u2019association radioth\u00e9rapie et antiangiog\u00e9niques\u00a0: \u00e0 propos d\u2019un cas","volume":"13","author":"Diaz","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2010.11.012_bib0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/CAD.0b013e328333d679","article-title":"Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib","volume":"21","author":"Chung","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canrad.2010.11.012_bib0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.canrad.2010.02.013","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: le foie","volume":"14","author":"De Bari","year":"2010","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321810008310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321810008310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:18:18Z","timestamp":1761135498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321810008310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1278321810008310"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2010.11.012","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soraf\u00e9nib et radioth\u00e9rapie dans le carcinome h\u00e9patocellulaire","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2010.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}